V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
J
JNJAI Stock Diagnostic Report

J&J's Stelara granted approval for pediatric ulcerative colitis

Johnson & Johnson's (J&J) Stelara has been approved as a treatment for pediatric ulcerative colitis.

View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

JNJ Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-28 21:13:18JNJ75MidView Report →
2026-08-28 18:57:22JNJ75MidView Report →
2026-08-25 11:08:11JNJ75MidView Report →
View Full History for JNJ (Blueprint) →